Neoplasms by Site

Also known as: Neoplasms by Sites

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB12565	Abexinostat	1	Completed	1
DB00958	Carboplatin	1	Terminated	1
DB12908	Denenicokin	1	Completed	1
DB18358	EO-3021	1	Recruiting	1
DB05827	G207	1	Active Not Recruiting	1
DB16024	Indocyanine green	1	Terminated	1
DB06132	Nivolumab	1	Completed	1
DB09035	Nivolumab	1	Completed	1
DB09330	Osimertinib	1	Terminated	1
DB00642	Pemetrexed	1	Terminated	1
DB04974	Rimiducid	1	Active Not Recruiting	1
DB12001	Abemaciclib	1 / 2	Recruiting	1
DB00958	Carboplatin	1 / 2	Active Not Recruiting	1
DB06374	Elacestrant	1 / 2	Recruiting	1
DB06205	Hyaluronidase (human recombinant)	1 / 2	Active Not Recruiting	1
DB09035	Nivolumab	1 / 2	Active Not Recruiting	2
DB09330	Osimertinib	1 / 2	Active Not Recruiting	1
DB00642	Pemetrexed	1 / 2	Active Not Recruiting	1
DB15822	Pralsetinib	1 / 2	Completed	1
DB14851	Relatlimab	1 / 2	Active Not Recruiting	1
DB17473	APL-502	2	Recruiting	1
DB16412	Adebrelimab	2	Recruiting	1
DB11363	Alectinib	2	Terminated	1
DB11885	Anlotinib	2	Completed	1
DB11885	Anlotinib	2	Not Yet Recruiting	1
DB11885	Anlotinib	2	Recruiting	2
DB00112	Bevacizumab	2	Unknown Status	1
DB14776	Camrelizumab	2	Active Not Recruiting	1
DB01101	Capecitabine	2	Completed	1
DB00958	Carboplatin	2	Not Yet Recruiting	1
DB00958	Carboplatin	2	Recruiting	1
DB00515	Cisplatin	2	Recruiting	1
DB00531	Cyclophosphamide	2	Completed	1
DB01234	Dexamethasone	2	Completed	1
DB01248	Docetaxel	2	Completed	1
DB05928	Dovitinib	2	Completed	1
DB00773	Etoposide	2	Recruiting	1
DB17120	Imifoplatin	2	Active Not Recruiting	1
DB17475	Incomplete Freund's adjuvant	2	Withdrawn	1
DB06186	Ipilimumab	2	Active Not Recruiting	1
DB13982	Lutetium Lu-177	2	Active Not Recruiting	1
DB16778	Lutetium Lu-177 vipivotide tetraxetan	2	Active Not Recruiting	1
DB11793	Niraparib	2	Unknown Status	1
DB09035	Nivolumab	2	Active Not Recruiting	1
DB09035	Nivolumab	2	Recruiting	1
DB09074	Olaparib	2	Recruiting	1
DB09567	Olive oil	2	Terminated	1
DB00526	Oxaliplatin	2	Completed	1
DB01229	Paclitaxel	2	Not Yet Recruiting	1
DB09073	Palbociclib	2	Recruiting	1
DB00642	Pemetrexed	2	Completed	1
DB14805	Piflufolastat F 18	2	Active Not Recruiting	1
DB14851	Relatlimab	2	Recruiting	1
DB05109	Trabectedin	2	Completed	2
DB00072	Trastuzumab	2	Completed	1
DB00399	Zoledronic acid	2	Completed	1
DB11363	Alectinib	2 / 3	Recruiting	1
DB11595	Atezolizumab	2 / 3	Recruiting	1
DB11986	Entrectinib	2 / 3	Recruiting	1
DB14776	Camrelizumab	3	Completed	1
DB01101	Capecitabine	3	Unknown Status	1
DB00958	Carboplatin	3	Active Not Recruiting	1
DB00958	Carboplatin	3	Completed	1
DB00515	Cisplatin	3	Active Not Recruiting	1
DB01248	Docetaxel	3	Unknown Status	1
DB00441	Gemcitabine	3	Active Not Recruiting	1
DB00441	Gemcitabine	3	Completed	1
DB06080	Linifanib	3	Terminated	1
DB01229	Paclitaxel	3	Active Not Recruiting	1
DB01229	Paclitaxel	3	Completed	1
DB09037	Pembrolizumab	3	Active Not Recruiting	1
DB00642	Pemetrexed	3	Active Not Recruiting	1
DB00642	Pemetrexed	3	Completed	1
DB15822	Pralsetinib	3	Active Not Recruiting	1
DB12048	Savolitinib	3	Active Not Recruiting	1
DB00398	Sorafenib	3	Terminated	1
DB01268	Sunitinib	3	Active Not Recruiting	1
DB00083	Botulinum toxin type A	4	Unknown Status	1
DB09153	Sodium chloride	4	Unknown Status	1
DB00515	Cisplatin	Not Available	Recruiting	1
DB14554	Dotatate	Not Available	Recruiting	1
DB13985	Lutetium Lu 177 dotatate	Not Available	Recruiting	1
DB12172	Nimorazole	Not Available	Recruiting	1